M&T Bank Corp Olema Pharmaceuticals, Inc. Transaction History

M&T Bank Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	SELL	$8.75 - $30.71 $93,931 - $329,671	-10,735 Closed	0 $0
Q3 2021 Oct 28, 2021	BUY	$22.96 - $30.13 $246,475 - $323,445	10,735 New	10,735 $296,000
Q1 2021 May 06, 2021	SELL	$27.81 - $53.64 $146,920 - $283,380	-5,283 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$37.09 - $54.5 $195,946 - $287,923	5,283 New	5,283 $254,000

138

58.8M

141K

23.1K

Ticker OLMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,419,600
Market Cap $243M
Description
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

Stay updated on M&T Bank Corp with notifications on news.